bendamustine mylan 100mg/ vial
bendamustine hydrochloride [monohydrate] -
bendamustine mylan 25mg/ vial
bendamustine hydrochloride [monohydrate] -
bendamustine eugia 2.5 mg/ml inj. sol. (pwdr., conc.) i.v. vial
eugia pharma (malta) ltd. - bendamustine hydrochloride monohydrate 26,14 mg - eq. bendamustine hydrochloride 25 mg - powder for concentrate for solution for infusion - bendamustine
bendamustine eugia 2.5 mg/ml inj. sol. (pwdr., conc.) i.v. vial
eugia pharma (malta) ltd. - bendamustine hydrochloride monohydrate 26,14 mg - eq. bendamustine hydrochloride 25 mg - powder for concentrate for solution for infusion - bendamustine
bendamustine s.k. 100 mg
k.s.kim international (sk- pharma) ltd., israel - bendamustine as hydrochloride monohydrate - powder for concentrate for solution for infusion - bendamustine as hydrochloride monohydrate 100 mg/vial - bendamustine - first-line of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotheraphy is not appropiate. indolent non-hodgkin’s lymphomas as monotheraphy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.
bendamustine s.k. 25 mg
k.s.kim international (sk- pharma) ltd., israel - bendamustine as hydrochloride monohydrate - powder for concentrate for solution for infusion - bendamustine as hydrochloride monohydrate 25 mg/vial - bendamustine - first-line of chronic lymphocytic leukaemia (binet stage b or c) in patients for whom fludarabine combination chemotheraphy is not appropiate. indolent non-hodgkin’s lymphomas as monotheraphy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen. follicular non-hodgkin’s lymphoma as first line treatment in combination with rituximab.
pfizer bendamustine concentrated injection
pfizer new zealand limited - bendamustine hydrochloride monohydrate 104.6mg equivalent to 100 mg bendamustine hydrochloride - concentrate for injection - 100 mg/4ml - active: bendamustine hydrochloride monohydrate 104.6mg equivalent to 100 mg bendamustine hydrochloride excipient: butylated hydroxyanisole ethanol macrogol 400 sodium hydroxide water for injection - first line treatment of chronic lymphocytic leukaemia (binet stage b or c).
pfizer bendamustine concentrated injection
pfizer new zealand limited - bendamustine hydrochloride monohydrate 26.1mg equivalent to 25 mg bendamustine hydrochloride - concentrate for injection - 25 mg/ml - active: bendamustine hydrochloride monohydrate 26.1mg equivalent to 25 mg bendamustine hydrochloride excipient: butylated hydroxyanisole ethanol macrogol 400 sodium hydroxide water for injection - first line treatment of chronic lymphocytic leukaemia (binet stage b or c).
bendamustine accord 25 mg/ml inf. sol. (conc.) i.v. vial
accord healthcare b.v. - bendamustine hydrochloride monohydrate 26,14 mg/ml - eq. bendamustine hydrochloride 25 mg/ml - concentrate for solution for infusion - bendamustine
bendamustine hcl
fresenius kabi oncology plc - bendamustine hydrochloride - pdr/conc/soln for infus - 25 milligram - bendamustine